Susquehanna International Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Susquehanna International Group’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-155,800	Closed	-$3.32M	–	13519
2024 Q1	$3.32M	Buy	+155,800	New	+$1.86M	﹤0.01%	4318

Susquehanna International Group's FUSN Position: Q2 2024 in Review

Susquehanna International Group sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 147,547 shares — an estimated $3.15M sold.

Susquehanna International Group first reported a position in FUSN in Q1 2021 and held it in 3 quarters. The position peaked at $3.15M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Susquehanna International Group reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 147,547 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.15M.
Susquehanna International Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2021 and held it in 3 quarters.
Susquehanna International Group's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.15M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.